Luciferase News and Research

RSS
mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

TriSb92 as a potential inhibitor against SARS-CoV-2 variants including Omicron

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Monitoring cellular metabolism for NAFLD/NASH liver disease research

Monitoring cellular metabolism for NAFLD/NASH liver disease research

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Rare disease diagnosis by 100,000 genomes pilot

Rare disease diagnosis by 100,000 genomes pilot

The autoantibody profile in COVID-19 patients with MIS-C

The autoantibody profile in COVID-19 patients with MIS-C

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

SARS-CoV-2 variants neutralized by camel nanobodies

SARS-CoV-2 variants neutralized by camel nanobodies

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

non-RBD mutation in SARS-CoV-2 variants enhances resistance to neutralizing antibodies

non-RBD mutation in SARS-CoV-2 variants enhances resistance to neutralizing antibodies

SARS-CoV-2 infection aided by antibody-dependent enhancement

SARS-CoV-2 infection aided by antibody-dependent enhancement

A novel FACS-based approach for SARS-CoV-2 serology

A novel FACS-based approach for SARS-CoV-2 serology

New vaccine platform can better induce anti-malaria immunity in the liver

New vaccine platform can better induce anti-malaria immunity in the liver

Expansion of seasonal betacoronavirus antibodies post-vaccination is associated with reduction in neutralization of the SARS-CoV-2 variants of concern

Expansion of seasonal betacoronavirus antibodies post-vaccination is associated with reduction in neutralization of the SARS-CoV-2 variants of concern

New study identifies novel compound as promising pan-coronavirus drug candidate

New study identifies novel compound as promising pan-coronavirus drug candidate

Study investigates the effects of calycosin on breast cancer cell progression

Study investigates the effects of calycosin on breast cancer cell progression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.